4//SEC Filing
SHREWSBURY STEPHEN B 4
Accession 0001209191-21-057275
CIK 0001445499other
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 4:57 PM ET
Size
14.9 KB
Accession
0001209191-21-057275
Insider Transaction Report
Form 4
SHREWSBURY STEPHEN B
Chief Medical Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2021-09-21−14,780→ 0 totalExercise: $1.97Exp: 2027-10-17→ Common Stock (14,780 underlying) - Exercise/Conversion
Stock Option (right to buy)
2021-09-21−53,954→ 29,587 totalExercise: $2.95Exp: 2029-02-07→ Common Stock (53,954 underlying) - Exercise/Conversion
Common Stock
2021-09-21$1.97/sh+14,780$29,117→ 14,780 total - Exercise/Conversion
Common Stock
2021-09-21$2.46/sh+4,650$11,439→ 19,430 total - Exercise/Conversion
Stock Option (right to buy)
2021-09-21−4,650→ 541 totalExercise: $2.46Exp: 2028-03-08→ Common Stock (4,650 underlying) - Exercise/Conversion
Common Stock
2021-09-21$2.95/sh+53,954$159,164→ 73,384 total
Footnotes (3)
- [F1]The option is 100% vested and exercisable.
- [F2]The option vested as to 25% of the total shares on February 13, 2019, then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on February 13, 2022, subject to the reporting person's provision of service to the issuer on each vesting date.
- [F3]The option vested as to 25% of the total shares on February 8, 2020, then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on February 8, 2023, subject to the reporting person's provision of service to the issuer on each vesting date.
Documents
Issuer
IMPEL NEUROPHARMA INC
CIK 0001445499
Entity typeother
Related Parties
1- filerCIK 0001413821
Filing Metadata
- Form type
- 4
- Filed
- Sep 21, 8:00 PM ET
- Accepted
- Sep 22, 4:57 PM ET
- Size
- 14.9 KB